B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRPM7

MOLECULAR TARGET

transient receptor potential cation channel subfamily M member 7

UniProt: Q96QT4NCBI Gene: 548228 compounds

TRPM7 (transient receptor potential cation channel subfamily M member 7) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TRPM7

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Adenosine Triphosphate0.691
2Colchicine0.691
3Cyclic AMP0.691
4Cyclic AMP0.691
5Emetine0.691
6Lasalocid Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates0.691
7Spermine0.691
8Sphingosine0.691

About TRPM7 as a Drug Target

TRPM7 (transient receptor potential cation channel subfamily M member 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented TRPM7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TRPM7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.